All News about Novartis Ag ADR
![](https://www.investors.com/wp-content/uploads/2018/04/STOCK-Novartis-02-shutter.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/10/25/juul_0.jpg?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/705709/a-customer-shops-at-a-pharmacy.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/10/25/image20.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/10/25/aapharma.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_8872.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_17984.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/22/live-maagazine-cover-image.jpg?width=1200&height=800&fit=crop)
Novartis Unveils New Strategy Focused On US-First, Eight Blockbuster Brands
September 22, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_1307.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/valuestock_image_3435.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/10/24/aapharma_0.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/10/17/screenshot_2022-10-17_at_5.57.35_pm.png?width=1200&height=800&fit=crop)
Pharma Trend Honors the Best Pharmaceutical Companies and the Most Innovative Products 2022
October 14, 2022
Via Magic PR
Exposures
COVID-19
![](https://cdn.benzinga.com/files/images/story/2022/10/14/joe_biden_and_saudi_crown_prince_july_2022.webp_.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/10/14/novartis.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/10/12/aapharma_0.png?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/703515/doctor-and-patient-talking.jpg)
![](https://g.foolcdn.com/editorial/images/703275/advisor-reviewing-data-on-a-laptop-with-a-family.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/09/27/aapharma_18.png?width=1200&height=800&fit=crop)
![](https://talkmarkets.com/images/logos/talkmarkets.png)
Strength Seen in Lilly (LLY): Can Its 4.9% Jump Turn into More Strength?
September 23, 2022
Via Talk Markets
![](https://www.investors.com/wp-content/uploads/2019/05/Stock-IonisHQ-01-company.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/09/23/aapharma_1.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/22/meta-privacy-_image_by_chetraruc_from_pixabay_-.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/03/safe-haven-1600.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/09/21/roomba_780.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/21/novartis_gilenya.jpg?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.